Dingal, Genrose .
HRN: 22-49-20 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/21/2023
CEFTRIAXONE 1G (VIAL)
01/21/2023
01/28/2023
IVTT
2g
Q24
T/c Typhoid Fever
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes